Sign In
Buy AVAI
$0.130
+0.0035 (+2.79%)
At Close: Aug 04, 2026
Avant Technologies Partner, Ainnova, to Sponsor and Present at 2025 Healthcare Innovation Summit in Mexico City
08:00am, Wednesday, 02'nd Apr 2025
LAS VEGAS , April 2, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company foc
Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company's Vision AI Platform
12:00pm, Tuesday, 25'th Mar 2025 InvestorsHub
LAS VEGAS, NV -- March 25, 2025 -- InvestorsHub NewsWire -- Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that the Company has started designing its clinical trial protocol ahead of a pre-submission meeting with the U.S. Food and Drug Administration (FDA). &nb...
Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company's Vision AI Platform
08:00am, Tuesday, 25'th Mar 2025
LAS VEGAS , March 25, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company fo
Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare
12:00pm, Monday, 10'th Mar 2025 InvestorsHub
LAS VEGAS, NV -- March 10, 2025 -- InvestorsHub NewsWire -- Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that Apollo Hospitals (Apollo) and Ainnova have officially established a strategic collaboration that marks a significant step forward in the integration of ar...
Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare
09:00am, Monday, 10'th Mar 2025
LAS VEGAS, NV / ACCESS Newswire / March 10, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology comp
Avant Brands Reports Record Fiscal 2024 Results
04:30pm, Friday, 28'th Feb 2025
Record Gross and Net Revenue: Generated $40.0 million Gross Revenue and $35.8 million Net Revenue in FY 2024. Record Export Wholesale Revenue: Generated $19.4 million in FY 2024 representing a 107% in
Avant Technologies Reaches Global Development and Licensing Deal with Partner, Ainnova Tech, Ahead of FDA Meetings
08:00am, Tuesday, 25'th Feb 2025
LAS VEGAS, NV / ACCESS Newswire / February 25, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology c
Avant Technologies JV Partner to Speak at AI Revolution in Healthcare Summit in Dubai
08:00am, Thursday, 13'th Feb 2025
LAS VEGAS, NEVADA / ACCESS Newswire / February 13, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technolo
Avant Technologies and Ainnova Advance Toward FDA Clinical Trial with Selection of Top CRO
08:00am, Tuesday, 11'th Feb 2025
LAS VEGAS, NV / ACCESS Newswire / February 11, 2025 / Avant Technologies, Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology
Avant Technologies to Play Key Role in Ainnova's U.S. FDA Clinical Study for Its Vision AI Platform
01:00pm, Monday, 27'th Jan 2025 InvestorsHub
LAS VEGAS, NV -- January 27, 2025 -- InvestorsHub NewsWire -- Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that Avant has started the budgeting process to fund Ainnova’s upcoming interactions with the U.S. Food and Drug Administration (FDA). Ainnova will be...
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases
01:00pm, Thursday, 16'th Jan 2025 InvestorsHub
LAS VEGAS, NV -- January 16, 2025 -- InvestorsHub NewsWire -- Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that Ainnova has started the process of implementing the 4 advanced AI-driven algorithms the company acquired last month into its state-of-the-art Vision AI plat...
Game Changing AI Applications from Healthcare to Marketing to Gaming
07:00am, Wednesday, 18'th Dec 2024
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - December 18, 2024) - Investorideas.com, a global news source and expert investing resource covering AI stocks issues a snapshot for t
Avant Technologies and Ainnova Secure Advanced AI Algorithms for Early Detection of Four Additional Diseases in the U.S.
01:00pm, Tuesday, 17'th Dec 2024 InvestorsHub
LAS VEGAS, NV -- December 17, 2024 -- InvestorsHub NewsWire -- Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), and its partner, Ainnova Tech, Inc., (Ainnova) a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced Ainnova’s acquisition of an exclusive license for 4 groundbreaking, AI-driven algorithms from one of Asia’s most respected and largest healthcare ins...
Avant Technologies and Ainnova Secure Advanced AI Algorithms for Early Detection of Four Additional Diseases in the U.S.
08:00am, Tuesday, 17'th Dec 2024
LAS VEGAS, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and its partner, Ainnova Tech, Inc. (Ainnova), a leading healthcare technology co
Avant Technologies' Partner, Ainnova, Signs Pilot Program with Roche to Combat Diabetic Retinopathy
01:00pm, Wednesday, 04'th Dec 2024 InvestorsHub
LAS VEGAS, NV -- December 4, 2024 -- InvestorsHub NewsWire -- Avant Technologies Inc.’s (OTCQB: AVAI) (“Avant” or the “Company”), partner, Ainnova Tech, Inc., (Ainnova) a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that the company has entered into a strategic alliance with global biotech, Roche, and leading pre-paid health plan provider, Salud 360, to begin a pilot prog...
